Amdocs Limited (NASDAQ:DOX) Receives $101.20 Average Target Price from Brokerages

Amdocs Limited (NASDAQ:DOXGet Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the five ratings firms that are currently covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average twelve-month price target among analysts that have covered the stock in the last year is $101.20.

Separately, StockNews.com cut shares of Amdocs from a “strong-buy” rating to a “buy” rating in a research report on Friday, February 28th.

Get Our Latest Analysis on DOX

Institutional Trading of Amdocs

Several hedge funds have recently bought and sold shares of DOX. Private Trust Co. NA grew its holdings in shares of Amdocs by 62.9% in the third quarter. Private Trust Co. NA now owns 303 shares of the technology company’s stock valued at $27,000 after acquiring an additional 117 shares in the last quarter. Brooklyn Investment Group bought a new position in Amdocs in the 3rd quarter worth about $28,000. Jones Financial Companies Lllp purchased a new position in Amdocs in the 4th quarter worth approximately $36,000. SBI Securities Co. Ltd. purchased a new stake in Amdocs during the fourth quarter valued at about $41,000. Finally, Global Retirement Partners LLC lifted its position in Amdocs by 45.6% in the 4th quarter. Global Retirement Partners LLC now owns 559 shares of the technology company’s stock worth $48,000 after buying an additional 175 shares during the last quarter. Institutional investors and hedge funds own 92.02% of the company’s stock.

Amdocs Stock Down 1.2 %

Shares of NASDAQ DOX opened at $90.95 on Wednesday. Amdocs has a 52-week low of $74.41 and a 52-week high of $93.34. The company has a debt-to-equity ratio of 0.22, a quick ratio of 1.20 and a current ratio of 1.16. The stock has a market cap of $10.27 billion, a P/E ratio of 21.10, a P/E/G ratio of 1.47 and a beta of 0.68. The firm has a 50 day moving average price of $87.89 and a 200 day moving average price of $87.33.

Amdocs (NASDAQ:DOXGet Free Report) last posted its earnings results on Tuesday, February 4th. The technology company reported $1.45 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.64 by ($0.19). Amdocs had a return on equity of 18.89% and a net margin of 10.19%. Analysts expect that Amdocs will post 6.21 EPS for the current year.

Amdocs Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Monday, March 31st will be paid a $0.527 dividend. This is a positive change from Amdocs’s previous quarterly dividend of $0.48. This represents a $2.11 dividend on an annualized basis and a dividend yield of 2.32%. The ex-dividend date of this dividend is Monday, March 31st. Amdocs’s payout ratio is currently 48.72%.

About Amdocs

(Get Free Report

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.

Featured Articles

Analyst Recommendations for Amdocs (NASDAQ:DOX)

Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.